vs
Eos Energy Enterprises, Inc.（EOSE）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
Eos Energy Enterprises, Inc.的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.6倍（$58.0M vs $35.5M），Eos Energy Enterprises, Inc.净利率更高（-207.7% vs -304.2%，领先96.6%），Eos Energy Enterprises, Inc.同比增速更快（699.6% vs 681.7%），RECURSION PHARMACEUTICALS, INC.自由现金流更多（$-47.3M vs $-75.2M）
Eos Energy Enterprises是一家专注于锌基长时储能电池技术研发、生产与商业化部署的企业，为公用事业、工商业、微电网等客户提供安全环保的储能解决方案，服务覆盖多区域市场，助力可再生能源消纳与电网稳定运行。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
EOSE vs RXRX — 直观对比
营收规模更大
EOSE
是对方的1.6倍
$35.5M
营收增速更快
EOSE
高出17.9%
681.7%
净利率更高
EOSE
高出96.6%
-304.2%
自由现金流更多
RXRX
多$27.9M
$-75.2M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $58.0M | $35.5M |
| 净利润 | $-120.5M | $-108.1M |
| 毛利率 | -93.8% | 59.8% |
| 营业利润率 | -140.1% | -304.8% |
| 净利率 | -207.7% | -304.2% |
| 营收同比 | 699.6% | 681.7% |
| 净利润同比 | 55.1% | 39.6% |
| 每股收益（稀释后） | $-0.53 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EOSERXRX
| Q4 25 | $58.0M | $35.5M | ||
| Q3 25 | $30.5M | $5.2M | ||
| Q2 25 | $15.2M | $19.2M | ||
| Q1 25 | $10.5M | $14.7M | ||
| Q4 24 | $7.3M | $4.5M | ||
| Q3 24 | — | $26.1M | ||
| Q2 24 | — | $14.4M | ||
| Q1 24 | — | $13.8M |
净利润EOSERXRX
| Q4 25 | $-120.5M | $-108.1M | ||
| Q3 25 | $-641.4M | $-162.3M | ||
| Q2 25 | $-222.9M | $-171.9M | ||
| Q1 25 | $15.1M | $-202.5M | ||
| Q4 24 | $-268.1M | $-178.9M | ||
| Q3 24 | — | $-95.8M | ||
| Q2 24 | — | $-97.5M | ||
| Q1 24 | — | $-91.4M |
毛利率EOSERXRX
| Q4 25 | -93.8% | 59.8% | ||
| Q3 25 | -111.2% | -183.8% | ||
| Q2 25 | -203.2% | -4.9% | ||
| Q1 25 | -234.7% | -48.0% | ||
| Q4 24 | -324.0% | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
营业利润率EOSERXRX
| Q4 25 | -140.1% | -304.8% | ||
| Q3 25 | -200.6% | -3327.6% | ||
| Q2 25 | -419.1% | -916.8% | ||
| Q1 25 | -506.2% | -1297.9% | ||
| Q4 24 | -712.8% | -4042.4% | ||
| Q3 24 | — | -377.1% | ||
| Q2 24 | — | -697.4% | ||
| Q1 24 | — | -698.4% |
净利率EOSERXRX
| Q4 25 | -207.7% | -304.2% | ||
| Q3 25 | -2102.1% | -3135.3% | ||
| Q2 25 | -1463.2% | -894.2% | ||
| Q1 25 | 144.7% | -1373.3% | ||
| Q4 24 | -3696.7% | -3935.5% | ||
| Q3 24 | — | -367.5% | ||
| Q2 24 | — | -676.6% | ||
| Q1 24 | — | -662.4% |
每股收益（稀释后）EOSERXRX
| Q4 25 | $-0.53 | $-0.17 | ||
| Q3 25 | $-4.91 | $-0.36 | ||
| Q2 25 | $-1.05 | $-0.41 | ||
| Q1 25 | $-0.20 | $-0.50 | ||
| Q4 24 | $-2.30 | $-0.56 | ||
| Q3 24 | — | $-0.34 | ||
| Q2 24 | — | $-0.40 | ||
| Q1 24 | — | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $568.0M | $743.3M |
| 总债务越低越好 | $813.3M | $9.6M |
| 股东权益账面价值 | $-2.2B | $1.1B |
| 总资产 | $885.2M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资EOSERXRX
| Q4 25 | $568.0M | $743.3M | ||
| Q3 25 | $58.7M | $659.8M | ||
| Q2 25 | $120.2M | $525.1M | ||
| Q1 25 | $82.6M | $500.5M | ||
| Q4 24 | $74.3M | $594.4M | ||
| Q3 24 | — | $427.6M | ||
| Q2 24 | — | $474.3M | ||
| Q1 24 | — | $296.3M |
总债务EOSERXRX
| Q4 25 | $813.3M | $9.6M | ||
| Q3 25 | $448.5M | $11.9M | ||
| Q2 25 | $445.3M | $14.2M | ||
| Q1 25 | $325.5M | $16.4M | ||
| Q4 24 | $316.9M | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
股东权益EOSERXRX
| Q4 25 | $-2.2B | $1.1B | ||
| Q3 25 | $-2.3B | $1.0B | ||
| Q2 25 | $-1.1B | $919.1M | ||
| Q1 25 | $-942.2M | $933.9M | ||
| Q4 24 | $-1.1B | $1.0B | ||
| Q3 24 | — | $524.6M | ||
| Q2 24 | — | $584.4M | ||
| Q1 24 | — | $401.2M |
总资产EOSERXRX
| Q4 25 | $885.2M | $1.5B | ||
| Q3 25 | $328.2M | $1.4B | ||
| Q2 25 | $361.0M | $1.3B | ||
| Q1 25 | $263.3M | $1.3B | ||
| Q4 24 | $260.3M | $1.4B | ||
| Q3 24 | — | $726.5M | ||
| Q2 24 | — | $775.9M | ||
| Q1 24 | — | $557.8M |
负债/权益比EOSERXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-50.3M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $-75.2M | $-47.3M |
| 自由现金流率自由现金流/营收 | -129.7% | -133.1% |
| 资本支出强度资本支出/营收 | 43.1% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-265.0M | $-378.3M |
8季度趋势，按日历期对齐
经营现金流EOSERXRX
| Q4 25 | $-50.3M | $-46.1M | ||
| Q3 25 | $-65.9M | $-117.4M | ||
| Q2 25 | $-66.1M | $-76.4M | ||
| Q1 25 | $-28.9M | $-132.0M | ||
| Q4 24 | $-42.7M | $-115.4M | ||
| Q3 24 | — | $-59.2M | ||
| Q2 24 | — | $-82.2M | ||
| Q1 24 | — | $-102.3M |
自由现金流EOSERXRX
| Q4 25 | $-75.2M | $-47.3M | ||
| Q3 25 | $-82.7M | $-117.6M | ||
| Q2 25 | $-73.2M | $-79.6M | ||
| Q1 25 | $-33.8M | $-133.8M | ||
| Q4 24 | $-55.8M | $-116.7M | ||
| Q3 24 | — | $-63.8M | ||
| Q2 24 | — | $-83.4M | ||
| Q1 24 | — | $-109.0M |
自由现金流率EOSERXRX
| Q4 25 | -129.7% | -133.1% | ||
| Q3 25 | -271.1% | -2272.5% | ||
| Q2 25 | -480.2% | -413.9% | ||
| Q1 25 | -323.6% | -907.4% | ||
| Q4 24 | -769.1% | -2567.7% | ||
| Q3 24 | — | -244.6% | ||
| Q2 24 | — | -578.5% | ||
| Q1 24 | — | -789.9% |
资本支出强度EOSERXRX
| Q4 25 | 43.1% | 3.5% | ||
| Q3 25 | 55.2% | 4.7% | ||
| Q2 25 | 46.2% | 16.4% | ||
| Q1 25 | 47.0% | 12.4% | ||
| Q4 24 | 180.6% | 28.6% | ||
| Q3 24 | — | 17.5% | ||
| Q2 24 | — | 8.2% | ||
| Q1 24 | — | 48.2% |
现金转化率EOSERXRX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -1.91× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
